Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chihiro Horii"'
Autor:
Akiko Kawade, Aya Yamamura, Moe Fujiwara, Saki Kobayashi, Shiho Mori, Chihiro Horii, Akari Hiraku, Sayo Suzumura, Kikuo Tsukamoto, Naoki Ohara, Rubii Kondo, Yoshiaki Suzuki, Hisao Yamamura
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 81-85 (2021)
Pulmonary arterial hypertension (PAH) is a rare, progressive, and fatal cardiovascular/lung disease. The incidence rate is affected by age. Monocrotaline (MCT, 60 mg/kg)-treated rats are widely used as an experimental PAH model. Here, we found that y
Externí odkaz:
https://doaj.org/article/b2a81d9e1b344219b4f548fdd892030d
Autor:
Aya Yamamura, Yoshiaki Suzuki, Moe Fujiwara, Naoki Ohara, Hisao Yamamura, Rubii Kondo, Chihiro Horii, Shiho Mori, Akari Hiraku, Akiko Kawade, Kikuo Tsukamoto, Saki Kobayashi, Sayo Suzumura
Publikováno v:
Journal of Pharmacological Sciences, Vol 147, Iss 1, Pp 81-85 (2021)
Pulmonary arterial hypertension (PAH) is a rare, progressive, and fatal cardiovascular/lung disease. The incidence rate is affected by age. Monocrotaline (MCT, 60 mg/kg)-treated rats are widely used as an experimental PAH model. Here, we found that y
Autor:
Atsuko Sakakibara, Takahide Taguchi, Yasuo Urata, Hideaki Takahashi, Hiroshi Hyakusoku, Chihiro Horii, Goshi Nishimura, Daisuke Sano, Norio Kondo, Masahiro Takahashi
Publikováno v:
Head & Neck. 36:411-418
Background Radioresistance remains a critical issue in the use of radiotherapy for the treatment of head and neck squamous cell carcinoma (HNSCC). This study evaluated the efficacy of combination treatment with OBP-301, a telomerase-specific replicat
Autor:
Hideaki, Takahashi, Hiroshi, Hyakusoku, Chihiro, Horii, Masahiro, Takahashi, Goshi, Nishimura, Takahide, Taguchi, Norio, Kondo, Atsuko, Sakakibara, Yasuo, Urata, Daisuke, Sano
Publikováno v:
Headneck. 36(3)
Radioresistance remains a critical issue in the use of radiotherapy for the treatment of head and neck squamous cell carcinoma (HNSCC). This study evaluated the efficacy of combination treatment with OBP-301, a telomerase-specific replication-selecti
Autor:
Saburo SONE, Chihiro HORII
Publikováno v:
Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 42:261-262